ECPG vs EW · P/E 6.3, rev $1.32B vs P/E 47, rev $1.39B
Encore Capital Group Inc (ECPG) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Encore Capital Group Inc (ECPG) is a credit services company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported ECPG revenue for 2024-12-31 was $1.32B. Net income was -$139.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. ECPG currently screens at market cap $1.73B and trailing P/E 6.3.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
ECPG currently screens at market cap $1.73B and trailing P/E 6.3. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the ECPG and EW stock pages for the full models.
Not investment advice.